This observation indicates that HBO therapy not only influenced the size and number of secondary spheres but also led to reduced protein expression of the critical stemness markers CD133, OCT4, and SOX2 in GBM cells (Figure 5). This evidence concerns the gene SOX2 and glioblastoma.